eversens SL

We develop innovative solutions based on exhaled breath biomarkers analysis providing a rapid, innocuous and non-invasive objective information about airway state to help healthcare professionals enhancing patient outcomes and contributing to the sustainability of the health care system.

We provide a global system needed for an efficient management of inflammatory respiratory diseases like asthma and COPD that combines the information collected by our range of evernoa devices which includes a wearable device ( evernoa HOME for remote monitoring) in parallel with POC devices (evernoa PRO for specialized care, evernoa PLUS for primary car) in a AI Software Platform making the information available for both clinicians and patients. Thus, evernoa SYSTEM allows (1) clinicians a more accurate diagnosis and follow up, as well as treatment personalization and adherence assessment (2) patient empowerment being more engaged in their therapy and supporting a better compliance (3) a direct connection between patient and doctor easing management and providing the needed feedback to maintain the disease under control with the minimum effective treatment dose while reducing exacerbations and doctor visits, hospitalizations required and ER visits. evernoa SYSTEM offers a unique solution that can help billions of people suffering from inflammatory respiratory diseases improve their quality of life and alleviate economical and assistance burden of health care systems